The Holy Grail of Immunology

Foundations | The Holy Grail of Immunology Click for larger version (27K) In 1983, Tak Mak's lab cloned the beta chain of the T-cell receptor, helping to accomplish what the immunology community had been anticipating for 20-plus years. But the T-cell receptor's structure was believed to be heterodimeric, and no one had deciphered what the other piece looked like. In 1984, Mak sketched his thoughts on its shape for a student, Pamela Ohashi, who then made antibodies to peptides, using the a

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In 1983, Tak Mak's lab cloned the beta chain of the T-cell receptor, helping to accomplish what the immunology community had been anticipating for 20-plus years. But the T-cell receptor's structure was believed to be heterodimeric, and no one had deciphered what the other piece looked like. In 1984, Mak sketched his thoughts on its shape for a student, Pamela Ohashi, who then made antibodies to peptides, using the already cloned beta-chain sequences as models. (It was Ohashi, now an immunologist, who kept Mak's original sketch.) In time, Mak's sketch was proven to be correct.

"At the very beginning, when thoughts are still brewing in your mind, and the facts are not yet in, you have to take a leap of faith," says Mak, of the University of Toronto. "And luckily, we turned out to be right. The alpha and beta chains are held together by intermolecular disulphide bonding and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies